Tommy G Thompson
CIK 1324863 · Chairman · last filed 2026-07-23
Tommy G Thompson is a Chairman who has filed 306 SEC Form 4 insider transactions across 10 companies since 2007. The most recent filing, for UTHR, was dated Jul 23, 2026. Across all open-market trades the lifetime net is −$13.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $12.4M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$12.39M
10
306
-$13.40M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| UTHR | Director | 16,680 | $523.63 | $8.73M | -$13.73M | 62 | 2026-07-23 |
| TXMD | Director | 37,491 | $2.06 | $77.2K | $310.4K | 31 | 2025-12-29 |
| HEALTHPEAK PROPERTIES, INC. (PEAK) Delisted | Director | 144,290 | $17.10 | $2.47M | $198.7K | 4 | 2025-05-28 |
| DOC | Director | 156,830 | $22.82 | $3.58M | $1.14M | 19 | 2024-03-01 |
| SCLXW | Director | — | $0.18 | — | $0 | 1 | 2023-01-17 |
| CENTENE CORP (CNTE) Delisted | Director | 287,334 | — | — | -$1.39M | 84 | 2022-01-04 |
| TYME TECHNOLOGIES, INC. (TYME) Delisted | Director | — | $0.31 | — | $0 | 3 | 2019-08-27 |
| PLUS THERAPEUTICS, INC. (CYTX) Delisted | Director | 144,801 | — | — | $30.2K | 10 | 2016-01-04 |
| Vyant Bio, Inc. (CGIX) Delisted | Director | 2,500 | $4.61 | $11.5K | $0 | 1 | 2013-10-15 |
| AGA Medical Holdings, Inc. (AGAM) Delisted | Director | 0 | — | — | $29.0K | 4 | 2010-11-18 |
Recent Filings
306 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-23 | UTHR | Grant (A) | — | $0 | EDGAR |
| 2026-03-26 | UTHR | Notice (144) | −2,000 | -$1.08M | EDGAR |
| 2026-03-26 | UTHR | Mixed | — | -$874.7K | EDGAR |
| 2026-03-05 | UTHR | Mixed | — | -$775.2K | EDGAR |
| 2026-03-04 | UTHR | Notice (144) | −2,000 | -$978.8K | EDGAR |
| 2025-12-29 | TXMD | Buy (P) | +8,400 | $14.0K | EDGAR |
| 2025-12-19 | UTHR | Mixed | — | -$362.9K | EDGAR |
| 2025-12-18 | UTHR | Notice (144) | −910 | -$455.5K | EDGAR |
| 2025-11-05 | TXMD | Grant (A) | — | $0 | EDGAR |
| 2025-09-10 | UTHR | Notice (144) | −4,560 | -$1.84M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.